- Investing Ideas
- /
- Top Growth Stocks
Top U.S. Growth Stocks
UPDATED Sep 25, 2023
What are the best U.S. Growth Stocks?
According to our Simply Wall St analysis these are the best U.S. growth companies. We look for companies with high forecasted growth and healthy balance sheets that can deliver sustained growth over the long term.
Our criteria to find Top Growth Companies
Growth
- Companies with sustained revenue growth that outperforms the market are attractive to investors. These companies are most likely to appreciate in share price over time.
What do we look for?
- Is the company forecast to have high earnings growth.
Healthy Balance Sheet
- A healthy balance sheet is essential to drive growth opportunities and sustain the business.
- Repayments on debt take precedence over other initiatives to improve shareholder returns, so investors want to make sure the company is comfortably positioned to cover its debts.
What do we look for?
- Does the company have a manageable level of debt.
- Is the company able to cover its interest repayments.
96 companies meet this criteria in the U.S. market
Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: ZVRA is expected to become profitable in the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 92.7% below our estimate of its fair value
Earnings are forecast to grow 70.37% per year
Risks
No risks detected for ZVRA from our risks checks.
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: SRPT is expected to become profitable in the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 71.4% below our estimate of its fair value
Earnings are forecast to grow 64.69% per year
Risks
Shareholders have been diluted in the past year
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: ACAD is expected to become profitable in the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 87.5% below our estimate of its fair value
Earnings are forecast to grow 61.26% per year
Earnings have grown 8.8% per year over the past 5 years
Risks
No risks detected for ACAD from our risks checks.
Luckin Coffee Inc. offers retail services of freshly brewed drinks, and pre-made food and beverage items in the People's Republic of China.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: LKNC.Y's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 64.4% below our estimate of its fair value
Earnings are forecast to grow 31.81% per year
Earnings grew by 167.3% over the past year
Risks
Shareholders have been diluted in the past year
Atour Lifestyle Holdings Limited, through its subsidiaries, provides lifestyle brands around hotel offerings in the People’s Republic of China.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: ATAT's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 30.7% below our estimate of its fair value
Earnings are forecast to grow 49.19% per year
Earnings grew by 103.4% over the past year
Risks
No risks detected for ATAT from our risks checks.
FTC Solar, Inc. provides solar tracker systems, software, and engineering services in the United States and internationally.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: FTCI is expected to become profitable in the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 94.7% below our estimate of its fair value
Earnings are forecast to grow 73.95% per year
Risks
Shareholders have been diluted in the past year
Significant insider selling over the past 3 months
Volatile share price over the past 3 months
Has less than 1 year of cash runway
CrowdStrike Holdings, Inc. provides cloud-delivered protection across endpoints and cloud workloads, identity, and data.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: CRWD is expected to become profitable in the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 32.7% below our estimate of its fair value
Earnings are forecast to grow 52.71% per year
Risks
Shareholders have been diluted in the past year
Significant insider selling over the past 3 months
Valaris Limited provides offshore contract drilling services to the international oil and gas industry.
Growth Criteria
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings: VAL's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market
High Growth Revenue
Future ROE
Rewards
Trading at 85.3% below our estimate of its fair value
Earnings are forecast to grow 84.1% per year
Risks
Significant insider selling over the past 3 months